Summary
Intraperitoneal injection of3H-GSH (15.4 mg, 0,5 μCi) 15 minutes before a similar i.p. treatment with Aflatoxin B1 (AFB1) (2mg/kg) showed less than 40% of the radioactivity in the 24 h urine and 30–35% in the bile. Analysis of the urine and bile samples by TLC and separation with XAD-2, showed only traces of the AFB1-GSH adduct present in the urine and 14% in the bile. AFB1 metabolites isolated from the urine of the3H-GSH treated rats were identical with those of rats treated with AFB1 only. While GSH Conjugate appears therefore to be a major component of biliary excretion of AFB1, it does not seem to be significant in the urinary excretion of the toxin.
Similar content being viewed by others
References
Newberne, P.M. and Butler, W.H. (1969) Cancer Res. 29, 236–250. Acute and chronic effects of aflatoxin on the liver of Domestic and laboratory animals. A. review.
Garner, R.C. Miller, E.C. and Miller, J.A. (1972) Liver microsomal metabolism of aflatoxin B1 to a reactive derivative toxic to Salmonella Typhimurium TA 1530 Cancer Res. 32, 2058–2066.
Garner, R.C. (1973) Chemical evidence for the forma-tion of a reactive aflatoxin B1 metabolite, by hamster liver microsomes. Febs. Lett. 36: 261–264.
Garner R.C. and Wright CM. (1975) Binding of (14C) aflatoxin B1 to cellular macromolecules in the rat and hamster Chem — Biol. Interactions. II, 123–131.
Gurtoo, H.L. and Dave, C. (1975). Invitro metabolic Conversion of aflatoxins and Benzo(a)pyrene to Nucleic acid binding metabolites. Cancer Res. 35, 382–389.
Miller, E.C. and Miller, J.A. (1966) Mechanisms of chemical Carcinogenesis. Nature of proximate carcinogens and interactions with macromolecules. Pharmacological Reviews 18, 805–837.
Miller, J.A. (1970). Carcinogenesis by chemicals: An overview- G.H.A. Clowes Memorial Lecture. Cancer Res. 30, 559–576.
Miller, J.A. and Miller E.C. (1977). The concept of reactive electrophilic metabolites in chemical carcino-genesis: Recent results with aromatic amines, safrole and as aflatoxin B1 In Biological Reactive intermediates: formation, toxicity and interactions Edited by Jollow, D.J. Kocsis, J.J. Synder, R. and Vainio, T.J., 6–24 Plenum press, N. York, London.
Mitchell, J.R., Jollow, D.J. Potter, W.Z., Gillette, J.R. and Brodie, B.B. (1973) Acetaminophen-induced hepatic necrosis iv. Protective role of glutathione. J. Pharmacol. Exptl. Ther. 187, 211–217.
Jollow, D.J., Mitchell, J.R., Zampaglione, N. and Gillette, J.R., (1974) Bromobenzene-Liver necrosis: Protective role of glutathione and evidence for 2.4 Bromobenzene oxide as the hepatotoxic metabolite Pharmacology 11:157–169.
Chasseud, L.F. (1976) Glutathione: Metabolism and function. Edited by Aras. I.M. and Jakoby, W.B. Raven Press, New York, pp 77–114.
White, I.N.H. (1976) The role of liver glutathione in the acute Toxicity of retrosine to rats. Chem. Biol. Inter. 13, 333–342.
Emerole G.O., Neskovic, N. and Dixon, R.L. (1979) The detoxication of aflatoxin B1 with glutathione. Xenobiotica 9, 737–743.
Ryan, A.J. and Bend, J.R. (1977) The metabolism of styrene oxide in the isolated perfused rat liver. Identification and quantitation of major metabolites. Amer. soc. pharmacol Exptl. Ther., 5(4) 363–367.
Bassir, O. and Osiyemi, F. (1967) Biliary excretion of aflatoxin in the rat after a single dose. Nature 215, 882.
Wogan, G.N., Edwards, G.S. Shank, R.C. (1967) Excretion and Tissue Distribution of Radioactivity from aflatoxin B1-14C in rats cancer Res. 27: 1729–1736.
Smith, R.L. (1973) The excretary function of bile: The elimination of drugs and toxic substances in bile. Chapman and hall London.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Emerole, G.O. Excretion of Aflatoxin B1 as a glutathione conjugate. European Journal of Drug Metabolism and Pharmacokinetics 6, 265–268 (1981). https://doi.org/10.1007/BF03189524
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189524